Kowa Gets Approval For Orange-Flavored Hyperkalemia Drug Kalimate
This article was originally published in PharmAsia News
Executive Summary
Kowa Pharmaceuticals attained approval for orange-flavored hyperkalemia agent Kalimate 20% oral solution (calcium polystyrene sulphonate) March 15.